Dr. Bennett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Avenue
Box 704
Rochester, NY 14642Phone+1 585-275-4915Fax+1 585-442-0039
Education & Training
- Boston University Medical CenterFellowship, Hematology and Medical Oncology, 1962 - 1963
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1960 - 1962
- Lawrence F. Quigley Memorial HospitalResidency, Internal Medicine, 1960 - 1960
- Boston University Medical CenterInternship, Internal Medicine, 1959 - 1960
- Boston University School of MedicineClass of 1959
Certifications & Licensure
- NY State Medical License 1969 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Standardization of Bone Marrow Reporting for Myelodysplastic Syndromes/Neoplasms on Behalf of the International Consortium for Myelodysplastic Syndromes/Neoplasms.Savanah D Gisriel, Fnu Aakash, John M Bennett, Robert P Hasserjian, Sanam Loghavi
Archives of Pathology & Laboratory Medicine. 2025-03-10 - Myeloid neoplasms with MYC-positive double minutes: towards recognition as a distinct entity.Isolde Summerer, Wencke Walter, Manja Meggendorfer, Torsten Haferlach, Frank Dicker
Blood Cancer Journal. 2025-03-03 - NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025.Peter L Greenberg, Richard M Stone, Yasmin Abaza, Aref Al-Kali, Sarah Anand
Journal of the National Comprehensive Cancer Network. 2025-03-01
Abstracts/Posters
- Combined Treatment with Lenalidomide and Epoetin Alfa Leads to Durable Responses in Patients with Epo-Refractory, Lower Risk Non-Deletion 5q [Del(5q)] MDS: Final Resul...John M. Bennett, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic SyndromesJohn M. Bennett, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- American Society of Clinical Oncology Honors Wilmot Physician with National AwardMay 23rd, 2018
- Spotlight on Wilmot Cancer Institute's 50th AnniversaryMay 18th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: